Heart surgery is done to correct problems with the heart. More than half a million heart surgeries are done each year in the United States for a variety of heart problems. Heart surgery is used to correct heart problems in children and adults. This article discusses heart surgeries for adults. For more information about heart surgeries for children, see the Diseases and Conditions Index articles on congenital heart defects, holes in the heart, and tetralogy of Fallot.
The most common type of heart surgery for adults is coronary artery bypass grafting (CABG). During CABG, surgeons use healthy arteries or veins taken from another part of the body to bypass (that is, go around) blocked arteries. CABG relieves chest pain and reduces the risk of heart attack.
Once more — and for the 20th year in a row — The Johns Hopkins Hospital has taken the top spot in U.S. News & World Report's annual rankings of American hospitals, placing first in five medical specialties and in the top five in 10 others.
The Virginia Commonwealth University Medical Center on Thursday was ranked in the 2010-2011 Best Hospitals in the country by U.S. News and World Report, making it one of 152 medical centers nationwide selected out of nearly 2,000 eligible institutions.
In its annual survey of "America's Best Hospitals," U.S. News & World Report has ranked St. Luke's Episcopal Hospital (SLEH) among the elite healthcare institutions in the nation in five major areas of care. This includes the Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital, listed in the top ten nationally in heart and heart surgery for the 20th consecutive year.
The University of Michigan Hospitals and Health Centers have been ranked among the country's best hospitals, placing 14th overall for the second consecutive year by U.S. News & World Report magazine. This year, U-M was ranked in every specialty and those rankings went up in 11 of the 16 specialties.
Professor John Fisher from The University of Leeds is speaking today (14 July) at the UK National Stem Cell Network Annual Science Meeting in Nottingham about his team's research into how biological scaffolding will pave the way for off- the-shelf tissue transplants.
Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according to a study in the July 8 Gene Therapy.
Not only are the children of the 15.3 million unemployed Americans feeling the impact of financial hardship brought on by the economic recession, many of their children may be experiencing an avoidable loss of healthcare coverage, according to new research by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center published in the July issue of Health Affairs.
Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice - still an elusive goal when treating humans with cancer, according to a study in the July 8 Gene Therapy.
Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, announced June 21st that it will fund nine research grants to improve the safety of red blood cell transfusions.
A statewide Ohio program significantly reduced the monthly rate of inappropriately scheduled births before 39 weeks gestation, helping to avoid expensive neonatal intensive care unit admissions and decrease the risk of infant deaths, according to two studies by the Ohio Perinatal Quality Collaborative recently published in the American Journal of Obstetrics & Gynecology.
St. Luke's Episcopal Hospital (St. Luke's) joins John Goss, M.D., in celebrating his milestone as he recently performed his 1,000th liver transplantation procedure. The largest liver transplant program in Houston's world-renowned Texas Medical Center, St. Luke's performs approximately 75 liver transplants annually. Additionally, St. Luke's liver transplant survival rate is the highest in the nation, with a one-year adult patient survival rate of 96.5 percent compared to the national expected survival rate of 89.38 percent.
Researchers in the University of Alabama at Birmingham (UAB) departments of Pathology, Microbiology and Surgery have received a $1.47 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study so-called red blood cell lesion, a term given to the potentially harmful changes in red blood cells that have been stored for longer times after collection.
Zynx Health, the market leader in providing evidence-based and experience-based clinical decision support solutions, today announced the successful implementation of ZynxOrder evidence-based order sets into the Riverside Health System electronic health record (EHR) system.
The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, is funding nine research grants to determine if the safety and efficacy of red blood cell transfusions vary depending on how long the cells have been stored. One of the grants supports the first large, multi-center, randomized clinical trial to compare outcomes in heart surgery patients who receive transfusions of red blood cells that have been stored for shorter or longer amounts of time.
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Signaling a new frontier in the treatment of congenital heart disease (CHD), The Children's Hospital of Philadelphia is the first hospital in our region to implant transcatheter pulmonary heart valves in children with heart defects. This minimally invasive procedure gives patients a non-surgical option in their ongoing treatment.
Four month old baby Finley Burton was taken for a routine visit to his doctor when two holes were detected in his heart. He subsequently underwent an intricate heart operation to close these holes that were making it difficult for his heart to pump out blood. Right after the operation he developed irregular, erratic heart beats that went over 200 beats per minute. This could have killed him but doctors in Britain found a miracle solution for the problem. They lowered his body temperature.
Kinetic Concepts, Inc. announced today it has received 510(k) clearance from the Food and Drug Administration for the Prevena Incision Management System, a negative pressure wound therapy product designed for management of surgically closed incisions. KCI estimates more than three million procedures are performed each year worldwide that could benefit from treatment with the Prevena System, representing a potential global opportunity greater than $1 billion.
Research released today at the American Society of Echocardiography (ASE) 21st Annual Scientific Sessions unveiled findings that will have a significant impact on the diagnosis and treatment of heart disease and the application of echocardiography in the future.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.